Mercury Therapeutics, Inc.
http://www.mtipharm.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Mercury Therapeutics, Inc.
Debiopharm signs diabetes deal with Mercury
Debiopharm and the US biotech company Mercury Therapeutics have signed an exclusive licence agreement for the development and commercialisation of the Swiss company's Debio 0930.
Going Gangbusters on Stroke
The field of acute ischemic stroke is highly promising but enormously risky and fraught with disappointment. With the exception of tPA, no one has ever demonstrated a pharmaco-mechanism which produces efficacy in the clinic. For now, the key to success for companies will be good efficacy and safety data. Start-ups will need partners, but even alliances with major pharmaceutical companies don’t represent a short-term validation of their efforts, since even big companies are stumbling in this field.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- Mercury Pharmaceuticals, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice